Literature DB >> 7199639

Recurrent embolic cerebral infarction and anticoagulation.

R L Koller.   

Abstract

A retrospective review of the hospital course of 44 patients with embolic cerebral infarction was carried out. Eleven patients (25%) suffered recurrent embolic infarction. Three of the recurrences were fatal. Two patients suffered a recurrence within 48 hours of the initial event, and an additional patient suffered a recurrence 6 days after the initial event. Sixteen embolic infarctions were managed with therapeutic anticoagulation within 48 hours without adverse effect. The clinical and experimental data concerning early anticoagulation after embolic infarction were reviewed. It appears that the risk of early anticoagulation is less than the risk of recurrent embolic infarction.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7199639

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  14 in total

Review 1.  Non-rheumatic atrial fibrillation: warfarin or aspirin for all?

Authors:  J Nolan; P Bloomfield
Journal:  Br Heart J       Date:  1992-12

2.  Neurology: anticoagulation therapy for cardiogenic cerebral emboli.

Authors:  J F Rothrock
Journal:  West J Med       Date:  1985-01

Review 3.  Drug treatment of stroke. Current status and future prospects.

Authors:  C A Sila; A J Furlan
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546

Review 4.  Atrial fibrillation, stroke and anticoagulation: what is to be done?

Authors:  J M Kitchens; K M Flegel
Journal:  J Gen Intern Med       Date:  1986 Mar-Apr       Impact factor: 5.128

5.  Controversies in the medical management of stroke.

Authors: 
Journal:  West J Med       Date:  1985-01

6.  Cooperative study on the value of long term anticoagulation in patients with stroke and non-rheumatic atrial fibrillation.

Authors:  J Lodder; M S Dennis; L Van Raak; L N Jones; C P Warlow
Journal:  Br Med J (Clin Res Ed)       Date:  1988-05-21

Review 7.  Trends and future developments in the pharmacological treatment of acute ischaemic stroke.

Authors:  G J del Zoppo; S Wagner; M Tagaya
Journal:  Drugs       Date:  1997-07       Impact factor: 9.546

8.  Silent cerebral ischemia in patients with chronic atrial fibrillation--a case-control study.

Authors:  M Guidotti; G Tadeo; S Zanasi; G Pellegrini
Journal:  Ir J Med Sci       Date:  1990-04       Impact factor: 1.568

Review 9.  Clinical evaluation and management of transient ischemic attacks.

Authors:  J F Rothrock
Journal:  West J Med       Date:  1987-04

Review 10.  Thrombolytic therapy in the treatment of stroke.

Authors:  G J del Zoppo
Journal:  Drugs       Date:  1997       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.